Abstract: Provided herein are pharmaceutical compositions comprising one or more muscarinic receptor antagonists ("MRA"), and atleast one other active ingredients selected from p2-agonists, p38 MAP Kinase inhibitors, PDE-IV inhibitors, and corticosteroids and optionally one or more pharmaceutically acceptable excipients. In addition, methods of treating autoimmune, inflammatory or allergic diseases or disorders are provided.
| # | Name | Date |
|---|---|---|
| 1 | 2794-del-2005-abstract.pdf | 2011-08-21 |
| 1 | 2794-del-2005-form-2.pdf | 2011-08-21 |
| 2 | 2794-del-2005-correspondence-others.pdf | 2011-08-21 |
| 2 | 2794-del-2005-form-1.pdf | 2011-08-21 |
| 3 | 2794-del-2005-correspondence-po.pdf | 2011-08-21 |
| 3 | 2794-del-2005-description (provisional).pdf | 2011-08-21 |
| 4 | 2794-del-2005-correspondence-po.pdf | 2011-08-21 |
| 4 | 2794-del-2005-description (provisional).pdf | 2011-08-21 |
| 5 | 2794-del-2005-correspondence-others.pdf | 2011-08-21 |
| 5 | 2794-del-2005-form-1.pdf | 2011-08-21 |
| 6 | 2794-del-2005-abstract.pdf | 2011-08-21 |
| 6 | 2794-del-2005-form-2.pdf | 2011-08-21 |